Elevated IL-9 in DKD may reflect an attempt to mitigate chronic inflammation and fibrosis, suggesting its potential as both a biomarker and therapeutic target in the later stages of diabetes-associated kidney disease. The gene discussed is IL9; the disease is diabetic kidney disease.